18000 STUDEBAKER RD, CERRITOS, CA
Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
2026 Annual Meeting of Stockholders - Proposals Voted by Shareholders
News
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Investor Presentation
Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
Appoints Kim Tzoumakas to Board of Directors
Q1
Q3
Q2
FY 2024
FY 2023 amended
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload